sábado, 14 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 4, 2025

Earnings live: Ulta stock pops, HPE falls with guidance in focus

View original at finance.yahoo.com
“Revenue of $9.7 billion grew 14% year over year but came in a bit light compared to estimates, as the Street was expecting $9.9 billion in revenue.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Enterprises want AI that can work within their secure data environments without compromise

    80% confidence
  • S&P 500 companies that beat earnings saw stock increase by 0.4% on average vs 0.9% five-year average

    80% confidence
  • Celestial AI acquisition strengthens Marvell's position in fastest-growing AI datacenter infrastructure opportunities

    80% confidence
  • All consumers are seeking value, and Dollar Tree thrives at intersection of value-seeking behavior with convenience and discovery

    80% confidence
  • Five Below saw nice traffic growth and growth in both new customers and retention

    80% confidence
  • AI clusters now measured in hundreds of thousands of GPUs and soon millions, pushing interconnect complexity

    80% confidence
  • Strong momentum continued into Q4 including excellent start to holiday season with record-breaking Thanksgiving weekend

    80% confidence
  • 83% of Q3 earnings surprises have been to the upside

    80% confidence
  • Companies that miss earnings saw stock decrease by 5% on average vs 2.6% five-year average

    80% confidence
  • Expansion of value concept beyond $5 price point worked well for growth

    80% confidence
  • Many consumers' wallets are pressured and they are seeking value as we look ahead to the holiday season

    80% confidence
  • Street is underestimating CrowdStrike growth potential as AI Revolution beneficiary

    80% confidence
  • Ulta is confident in plans to drive excitement and deliver for guests during holiday season

    80% confidence
  • Snowflake partnership is meaningful step toward making frontier AI genuinely useful for businesses

    80% confidence
  • Consumer and competitive environment has grown notably tougher for food retailers like Kroger

    80% confidence
  • Sentiment toward food retailers seems to have soured over the past few months

    80% confidence
  • Analysts expect 13.4% jump in S&P 500 EPS during Q3 2025

    80% confidence
  • Q3 sales were strongest in 13 quarters, reflecting acceleration of Bold New Chapter strategy

    80% confidence
  • Q2 results are strongest in Credo's history, reflecting AI training and inference cluster build-out

    80% confidence
  • 95% of S&P 500 companies have reported Q3 earnings as of Nov 21, 2025

    80% confidence
  • Q3 was exceptional quarter with existing customers expanding and net-new customer additions showing strength

    80% confidence

Data points we hold from this source

Snowflake Inc. · product revenue guidance1.19-1.2 billion_USD
Snowflake Inc. · revenue guidance4.44 billion_USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com